Integer Holdings Corp(ITGR) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 4:09 PM ET (Korea 9/12 05:09)
Full metrics table
| Index | RUT | P/E | 34.35 | EPS (ttm) | 3.67 | Insider Own | 1.29% | Shs Outstand | 34.0M | Perf Week | 0.4% |
| Market Cap | 4.28B | Forward P/E | 18.36 | EPS next Y | 11.5% | Insider Trans | -2.28% | Shs Float | 33.5M | Perf Month | 0.74% |
| Enterprise Value | 5.63B | PEG | 4.05 | EPS next Q | 1.68 | Inst Own | 120.32% | Short Float | 7.74% | Perf Quarter | 36.81% |
| Income | 0.13B | P/S | 2.33 | EPS this Y | -3.85% | Inst Trans | 4.91% | Short Ratio | 2.82 | Perf Half Y | 51.26% |
| Sales | 1.84B | P/B | 2.49 | EPS next 5Y | 4.53% | ROA | 3.78% | Short Interest | 2.60M | Perf YTD | 60.65% |
| Book/sh | 50.56 | P/C | 200.33 | EPS past 3/5Y | 13.83% 4.37% | ROE | 7.5% | 52W High | -0.63% ($126.79) | Perf Year | 20.89% |
| Cash/sh | 0.63 | P/FCF | 38.25 | Sales past 3/5Y | 10.24% 11.47% | ROIC | 4.18% | 52W Low | 103.23% ($62.00) | Perf 3Y | 53.83% |
| Dividend Est. | - | EV/EBITDA | 17.44 | EPS Y/Y TTM | 53.15% | Gross Margin | 22.8% | Volatility(W/M) | 0.36% 0.26% | Perf 5Y | 34.03% |
| Dividend TTM | - | EV/Sales | 3.06 | Sales Y/Y TTM | 2.62% | Oper. Margin | 10.03% | ATR (14) | 0.89 | Perf 10Y | 436.86% |
| Dividend Ex-Date | - | Quick Ratio | 2.41 | EPS Q/Q | -33.29% | Profit Margin | 6.98% | RSI (14) | 76.15 | Recom | 3.09 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.73 | Sales Q/Q | -2.74% | SMA20 | 0.42% ($125.47) | Beta | 0.58 | Target Price | $120.6 |
| Payout | - | Debt/Eq | 0.79 | Earnings | 2026/8/3 | SMA50 | 10.92% ($113.6) | Rel Volume | 0.49 | Prev Close | $126.05 |
| Employees | 11000 | LT Debt/Eq | 0.79 | EPS/Sales Surpr. | 16.04% 2.89% | SMA200 | 36.98% ($91.98) | Avg Volume(3M) | 0.92M | Price | $126 |
| IPO | 2000/9/29 | Option/Short | Yes/Yes | Trades | 4175 | Volume | 449,909 | Change | -0.04% |
Company
ITGR is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🔧 This is a US medical device company that provides components and contract manufacturing for medical devices. It designs and manufactures components for cardiovascular and neuromodulation medical devices, as well as medical-grade batteries, supplying them to medical device companies, with exposure to the outsourcing demand in the medical device sector. It is a company operating in the medical device contract manufacturing field.
Over the past 1 year, on the higher side
1% below its 1-year high.
ITGR makes money exceptionally well
10.03% of revenue is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by -3.9% this year.
Tap to view numbers
The price looks about right
Trading at 34.4 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have paid off
Would have changed by +53.8% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 120.3%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
XHE 0.02%
PSCH 0.02%
ACVT 0.01%
LFSC 0.01%
YUNG 0.01%It ranks #4 in the industry
Based on market cap of $4B.
ITGR $4B PER 34.4
ABT $176B PER 33.0
MDT $116B PER 22.4
SYK $106B PER 28.6
FAQ
What kind of company is ITGR?
ITGR belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of ITGR?
The market cap of ITGR is approximately $4.3B, ranking 1,510 within its sector.
What is the P/E ratio of ITGR?
ITGR has a P/E ratio of approximately 34.4x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for ITGR?
ITGR has recorded a 52-week high of $126.79 and a low of $62.00.
